Valiant Laboratories Ltd

Stage 2 · Advancing · week 12Setup 5.8 ★ FairWeak −1.4

As of 20 Nov 2026, Valiant Laboratories is in Stage 2, the uptrend phase, now in week 12 (since 25 Aug 2026). It closed at ₹94.91, 32.6% below its 52-week high and above its 200-day average, which is rising. In Health Care, 34.7% of stocks are in Stage 2.

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. More about the company

₹94.9
Close, 20 Nov 2026
-1.99% on the day
₹515 Cr · Small cap
Market DowntrendHealth Care 34.7% in Stage 2-11.4 pts / 20dPharmaceuticals 42.4%-13.9 pts

Pro read

Pro

Our read

Uptrend, resting below its 50-day

Setup score

5.8 ★ Fair

RS rank

Edge

Weak −1.4

VALIANTLAB is about 3 months into its Stage 2 advance, 21% below its 50-day average and 33% under its 52-week high. A pause below the 50-day inside an uptrend is the weakest spot of the move until it closes back above the line.

Its relative strength is 79 of 99, above the middle among NSE stocks over the past year. Pharmaceuticals ranks 7 of 106 industries by the strength of its stocks, among the leaders.

Stocks with a similar setup at this point in their move ran 1.4 points behind the average stock over the next 30 sessions on average, after costs, and their typical best close within 60 sessions was 12% above entry.

The trend read holds while it stays in Stage 2. A close below ₹120, its 50-day average, would put it at rest; ₹113, 20% under its 52-week high of ₹141, is where a trailing stop would sit.

Setup-score rank among Stage 2 peers: #42 of 50 in Pharmaceuticals · #51 of 61 in Health Care

Is VALIANTLAB early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2023-10-06 → 2026-11-20
S? 43w
S4 41w
S4 35w
2023-10-062026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 43w → S4 41w → S1 7w → S2 5w → S3 2w → S4 35w → S1 7w → S2 5w → S3 2w → S4 3w → S3 1w → S2 13w current
Total tracked: 163 weeks across 12 stage runs.

VALIANTLAB among Pharmaceuticals46th of 118 by relative strength

All 118 →
Stocks in Pharmaceuticals ranked by relative strength, with stage and one-month change
#StockStageRS1M
1BLISSGVSStage 2 · wk 4999+4.6%
2KPLStage 2 · wk 4499+20.5%
3FREDUNStage 2 · wk 3398+24.0%
4VENUSREMStage 3 · wk 1098−1.5%
5RUBICONStage 3 · wk 498+18.7%
6SAKARStage 2 · wk 5598+13.1%
7BAFNAPHStage 2 · wk 2398+1.9%
8INDSWFTLABStage 2 · wk 2398−7.4%
…46VALIANTLABStage 2 · wk 1279−29.0%
vs 52W High
-32.6%
₹50.9 lo₹140.8 hi
32.6% below 52W high, far from high
How far this stock is from its 52-week high. A stock a little below its high with its Stage 2 structure intact is in a pullback, not a breakdown.
Stage Maturity
Week 12
1w13w26w
Week 12, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
15.9%
200 DMA: ₹81.9 · rising
The stock is above its 200-day average, the long-term trend line. That is where a Stage 2 advance normally trades.
Rel Volume
0.26x
vs 50-day avg
Volume was well below average. In a Stage 2 advance, quiet sessions read as the stock resting, not being sold.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-29.0%
3M
+3.2%
6M
+24.0%
YTD
+35.6%
1Y
+19.1%
Sector
Health Care
↓ Peaking
Stage 2%
34.7%
20d Δ
-11.4pp
1M return
+11.5%
3M return
+3.8%
Sector Stage-2 % · last 20 days
This stock ranks #39 of 58 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
42.4%
20d Δ
-13.9pp
1M return
+8.3%
3M return
+2.1%
Industry Stage-2 % · last 20 days
Ranks #32 of 48 Stage 2 stocks in this industry.
Scan Membership
Not in any scan now.
Last appeared 4 Nov 2026
Last appeared 25 Aug 2026
31 appearances in the last 60 days.
Recent Stage Timeline
2026-11-20S2
Wk 12 · Vol 0.26x
2026-11-19S2
Wk 12 · Vol 0.05x
2026-11-18S2
Wk 12 · Vol 0.06x
2026-11-17S2
Wk 12 · Vol 0.03x
2026-11-16S2
Wk 12 · Vol 0.07x
2026-11-13S2
Wk 11 · Vol 0.03x
2026-11-12S2
Wk 11 · Vol 0.04x
2026-11-11S2
Wk 11 · Vol 0.04x
2026-11-09S2
Wk 11 · Vol 0.04x
2026-11-06S2
Wk 11 · Vol 0.03x
2026-11-05S2
Wk 10 · Vol 0.04x
2026-11-04S2
Wk 10 · Vol 0.08x
Moving averages & range
50 DMA
₹120.4
200 DMA
₹81.9
52W High
₹140.8
52W Low
₹50.9
5D Low
₹94.9
Resistance levels (recent highs)
20d High
₹128.4
60d High
₹140.8
120d High
₹140.8
250d High
₹140.8
Next resistance
+35.3%
to 20d High
P/E (TTM)
37.0
Forward —
Earnings Growth (YoY)
+100.0%
Revenue +152.7%
ROE
+5.0%
Profit margin +4.3%
Dividend Yield
0.00%
P/B 1.6

Valiant Laboratories: quick answers

What stage is Valiant Laboratories in?

As of 20 Nov 2026, Valiant Laboratories (VALIANTLAB) is in Stage 2, the uptrend phase. It entered Stage 2 on 25 Aug 2026 and is in week 12. What the four stages mean

Is Valiant Laboratories in an uptrend?

Yes. Valiant Laboratories is in a Stage 2 uptrend. It trades 15.9% above its 200-day average, which is rising.

How far is Valiant Laboratories from its 52-week high?

Valiant Laboratories closed at ₹94.91 on 20 Nov 2026, 32.6% below its 52-week high of ₹141. Its 52-week low is ₹50.93.

How has Valiant Laboratories performed over the past year?

As of 20 Nov 2026, Valiant Laboratories is up 19.1% over the past year and up 35.6% so far in 2026.

Which sector and industry is Valiant Laboratories in?

Valiant Laboratories is in the Pharmaceuticals industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Pharmaceuticals

About this companyHealth Care· Pharmaceuticals

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.